|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-4-24
|
|
pubmed:abstractText |
The aromatase inhibitors Anastrozole, Letrozole (type 2 nonsteroidal aromatase inhibitors: n-SAI) and Exemestane (type 1 steroidal aromatase inactivator) are used respectively as first- and second-line hormonal therapy in postmenopausal metastatic breast cancer women. Few clinical data are published on the sequential use of different classes of aromatase inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0735-7907
|
|
pubmed:author |
pubmed-author:AlimontiAndreaA,
pubmed-author:BriaEmilioE,
pubmed-author:CarliniPaoloP,
pubmed-author:CognettiFrancescoF,
pubmed-author:CrestiNicolaN,
pubmed-author:Di CosimoSerenaS,
pubmed-author:FabiAlessandraA,
pubmed-author:FerrettiGianluigiG,
pubmed-author:GiannarelliDianaD,
pubmed-author:MichelottiAndreaA,
pubmed-author:MilellaMicheleM,
pubmed-author:PapaldoPaolaP,
pubmed-author:PellegriniManuelaM,
pubmed-author:RicciSergioS,
pubmed-author:RuggeriEnzo MariaEM,
pubmed-author:SalesiNelloN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
102-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17453821-Adult,
pubmed-meshheading:17453821-Aged,
pubmed-meshheading:17453821-Aged, 80 and over,
pubmed-meshheading:17453821-Androstadienes,
pubmed-meshheading:17453821-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17453821-Aromatase Inhibitors,
pubmed-meshheading:17453821-Breast Neoplasms,
pubmed-meshheading:17453821-Female,
pubmed-meshheading:17453821-Humans,
pubmed-meshheading:17453821-Middle Aged,
pubmed-meshheading:17453821-Nitriles,
pubmed-meshheading:17453821-Postmenopause,
pubmed-meshheading:17453821-Treatment Outcome,
pubmed-meshheading:17453821-Triazoles
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patients.
|
|
pubmed:affiliation |
Department of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy. pcarlini@iol.it
|
|
pubmed:publicationType |
Journal Article
|
